Header Logo

Connection

SANGEETA GOSWAMI to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications SANGEETA GOSWAMI has written about Antibodies, Monoclonal, Humanized.
SANGEETA GOSWAMI
Connection Strength
0.086
Antibodies, Monoclonal, Humanized
  1. Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma. Nat Med. 2020 12; 26(12):1845-1851.
    View in: PubMed
    Score: 0.086
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.